LABS, Inc. Promotes Chad Ronholdt to VP of Strategic Development

CENTENNIAL, Colo., June 6, 2011 /PRNewswire/ -- LABS, Inc., the recognized leader in microbiology, infectious disease screening, immunological  and cell/molecular biology testing for the transplant and biomedical sciences communities, today announced that Chad Ronholdt has been promoted to Vice President of Strategic Development following two years with the company and accomplishments that have grown the LABS, Inc. client base significantly.

In Ronholdt's previous role as Director of Business Development he afforded many strategic wins for LABS, Inc., including expanding the company's depth in the microbiology, infectious disease, immunological, biologics and medical device testing offerings and growth into the molecular and cellular biology industries. In the new role of VP of Strategic Development, Ronholdt will continue to lead the laboratory's growth into new markets, and oversee the development of new proprietary offerings.

"Chad has been pivotal in accelerating LABS' growth, by securing new clients and innovating new products to best serve our customers," said Elizabeth Hearty, Chief Executive Officer of LABS Inc. "We are pleased to announce Chad's expanded responsibility in the role of VP, and are confident he will remain fundamental in the evolution of LABS, Inc., which continues its expansion."

Ronholdt has led a distinguished career in the field of medical devices and biologics for 13 years, with a solid record of transforming fundamental scientific concepts into effective products used by surgeons worldwide. He has worked with various tissue allograft and orthopaedic medical device producers as well as several research laboratories in both scientific and strategic capacities. He also served as the Chair of the American Association of Tissue Banks (AATB) Scientific and Technical Affairs Committee from 2005 to 2008.  

About LABS, Inc.

LABS, Inc. is the premier transplant medicine reference laboratory in the country that brings unparalleled consultative expertise and industry knowledge to its clients. Our FDA registered, CLIA-certified and CAP accredited testing is focused on four core competencies; infectious disease screening, microbiology, immunogenetics and cell/molecular biology, while serving  clients in a variety of industries from transplant and transfusion to implantable biologics and tissue-based devices.. LABS, Inc. is committed to respectfully fulfilling the wishes of donors by ensuring the gift is able to generate positive patient outcomes. LABS, Inc. employs over 180 people. The company headquarters is located in Centennial, CO with satellite facilities in St. Louis, MO and Philadelphia, PA. To learn more, visit www.labs-inc.org.

SOURCE LABS, Inc.